Pioneer Group
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
NuVision Biotherapies
5 Feb 2026
NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions
NuVision Biotherapies develops ophthalmic products based on amniotic membrane tissue. Its treatments are used to support healing after eye surgery and manage chronic eye conditions.
ImmuONE
13 Mar 2025
ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing
ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.
Pioneer Group
More venture news
- 17 Mar 2026
Sequential BioSequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients
EquityLife Sciences - 10 Mar 2026
DealFlowAgentDealFlowAgent raises £570k in funding led by Long Journey for M&A platform for SME firms
EquityEnterprise - 10 Mar 2026
AvvokaAvvoka secures £14m in funding from Valhalla Ventures for legal drafting software platform
EquityLegal